Does Hyperglycemia at Discharge Predict Return Visits by Type 2 Diabetics?

There was no linear relationship between discharge glucose levels and 7-day outcomes.

Investigators at a single U.S. emergency department (ED) performed a chart review to determine whether there was a relationship between glucose level at ED discharge and 7-day outcomes.

Included were 566 ED encounters with 422 unique patients. Main outcomes were occurrence of diabetic ketoacidosis or hyperosmolar hyperglycemic state, repeat ED visit for hyperglycemia, or hospitalization for any reason within 7 days of the index ED visit. Generalized estimating equation modeling was performed to seek evidence of a linear relationship between ED discharge glucose level and outcomes. None was found.

Reviewing Author

Daniel J. Pallin, MD, MPH

Disclosures

Consultant/Advisory BoardPortola Pharmaceuticals, Inc.

Speaker’s BureauPeerView Institute for Medical Education

Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals

Daniel J. Pallin, MD, MPH

Disclosures

Consultant/Advisory BoardPortola Pharmaceuticals, Inc.

Speaker’s BureauPeerView Institute for Medical Education

Does Hyperglycemia at Discharge Predict Return Visits by Type 2 Diabetics?

Topics

Reviewing Author